Free Trial

Kodiak Sciences (KOD) Stock Forecast & Price Target

$3.00
+0.24 (+8.70%)
(As of 07/12/2024 ET)

Kodiak Sciences - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$5.50
83.33% Upside
High Forecast$12.00
Average Forecast$5.50
Low Forecast$2.00
TypeCurrent Forecast
7/14/23 to 7/13/24
1 Month Ago
6/14/23 to 6/13/24
3 Months Ago
4/15/23 to 4/14/24
1 Year Ago
7/14/22 to 7/14/23
Consensus Rating
Reduce
Reduce
Reduce
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
3 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
Sell
3 Sell rating(s)
3 Sell rating(s)
3 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$5.50$5.50$5.50$12.86
Forecasted Upside83.33% Upside51.20% Upside51.20% Upside56.28% Upside
Get Kodiak Sciences Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for KOD and its competitors with MarketBeat's FREE daily newsletter.

KOD Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

KOD Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Kodiak Sciences Stock vs. The Competition

TypeKodiak SciencesMedical CompaniesS&P 500
Consensus Rating Score
1.71
2.71
2.50
Consensus RatingReduceModerate BuyModerate Buy
Predicted Upside83.33% Upside994.26% Upside9.17% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/4/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$3.00 ➝ $5.00+12.87%
4/1/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderweight ➝ Underweight$2.00 ➝ $3.00-40.48%
12/11/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingSell$2.00-36.71%
11/17/2023Capital One Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Z. Jallah
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$7.00 ➝ $12.00+525.00%
7/25/2023Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Gataulin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
7/24/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underweight
7/24/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
11/14/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$12.00 ➝ $9.00+19.05%
11/10/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$8.00 ➝ $6.00-10.85%
8/9/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$10.00 ➝ $15.00+35.01%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 03:26 PM ET.

KOD Forecast - Frequently Asked Questions

What is Kodiak Sciences' forecast for 2024?

According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Kodiak Sciences is $5.50, with a high forecast of $12.00 and a low forecast of $2.00.

Should I buy or sell Kodiak Sciences stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Kodiak Sciences in the last twelve months. There are currently 3 sell ratings, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "reduce" KOD shares.

Does Kodiak Sciences's stock price have much upside?

According to analysts, Kodiak Sciences's stock has a predicted upside of 51.20% based on their 12-month stock forecasts.

Do Wall Street analysts like Kodiak Sciences more than its competitors?

Analysts like Kodiak Sciences less than other "medical" companies. The consensus rating for Kodiak Sciences is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how KOD compares to other companies.


This page (NASDAQ:KOD) was last updated on 7/13/2024 by MarketBeat.com Staff

From Our Partners